US Stock MarketDetailed Quotes

Soleno Therapeutics (SLNO)

Watchlist
  • 53.010
  • +0.020+0.04%
Close May 15 16:00 ET
  • 53.020
  • +0.010+0.02%
Post 20:01 ET
2.76BMarket Cap27.47P/E (TTM)

Soleno Therapeutics (SLNO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
94.6M
190.41M
91.73M
66.02M
32.66M
0
0
0
0
0
Operating revenue
--94.6M
--190.41M
--91.73M
--66.02M
--32.66M
--0
--0
--0
--0
--0
Cost of revenue
1.2M
2.7M
863K
1.14M
696K
0
0
0
0
0
Gross profit
93.41M
187.71M
90.87M
64.88M
31.96M
0
0
0
0
0
Operating expense
44.11%61.64M
-6.33%172.76M
-14.21%50.44M
-46.86%42.16M
60.93%37.39M
85.39%42.78M
376.93%184.43M
358.25%58.79M
747.51%79.34M
179.55%23.23M
Selling and administrative expenses
72.15%50.37M
24.81%132.13M
9.58%40.88M
-31.39%33.75M
159.33%28.24M
245.36%29.26M
685.26%105.86M
801.04%37.3M
1,382.73%49.2M
243.61%10.89M
-General and administrative expense
72.15%50.37M
----
----
----
----
245.36%29.26M
685.26%105.86M
801.04%37.3M
1,382.73%49.2M
243.61%10.89M
Research and development costs
-16.59%11.27M
-48.29%40.63M
-55.52%9.56M
-72.11%8.41M
-25.89%9.15M
-7.43%13.52M
211.91%78.57M
147.28%21.49M
398.73%30.14M
140.07%12.34M
Operating profit
174.25%31.76M
108.11%14.95M
168.77%40.43M
128.64%22.72M
76.65%-5.42M
-85.39%-42.78M
-376.93%-184.43M
-358.25%-58.79M
-747.51%-79.34M
-179.55%-23.23M
Net non-operating interest income expense
84.52%3.64M
-2.92%11.48M
20.64%3.78M
8.68%3.91M
-39.71%1.82M
-5.15%1.97M
358.53%11.82M
46.18%3.13M
1,966.67%3.6M
1,950.34%3.01M
Non-operating interest income
47.91%4.93M
40.66%16.95M
52.45%5.13M
47.33%5.3M
5.94%3.19M
60.38%3.33M
367.49%12.05M
56.95%3.37M
1,966.67%3.6M
1,950.34%3.01M
Non-operating interest expense
-5.07%1.29M
2,270.56%5.48M
483.98%1.35M
--1.39M
--1.38M
--1.36M
--231K
--231K
--0
--0
Other net income (expense)
83.69%-484K
-70.76%-5.54M
-161.16%-854K
29.99%-614K
32.74%-1.1M
-639.90%-2.97M
-11.95%-3.24M
46.48%-327K
47.61%-877K
-424.68%-1.64M
Special income (charges)
83.69%-484K
-70.76%-5.54M
-161.16%-854K
29.99%-614K
32.74%-1.1M
-639.90%-2.97M
-19.45%-3.24M
69.75%-327K
14.10%-877K
-423.00%-1.64M
-Less:Restructuring and merger&acquisition
-83.69%484K
70.76%5.54M
161.16%854K
-29.99%614K
-32.74%1.1M
639.90%2.97M
19.45%3.24M
-69.75%327K
-14.10%877K
423.00%1.64M
Income before tax
179.76%34.91M
111.88%20.89M
177.45%43.36M
133.95%26.01M
78.46%-4.71M
-104.57%-43.77M
-351.04%-175.85M
-395.59%-55.98M
-605.42%-76.62M
-157.86%-21.85M
Income tax
3.54M
Net income
171.68%31.38M
111.88%20.89M
177.45%43.36M
133.95%26.01M
78.46%-4.71M
-104.57%-43.77M
-351.04%-175.85M
-395.59%-55.98M
-605.42%-76.62M
-157.86%-21.85M
Net income continuous Operations
171.68%31.38M
111.88%20.89M
177.45%43.36M
133.95%26.01M
78.46%-4.71M
-104.57%-43.77M
-351.04%-175.85M
-395.59%-55.98M
-605.42%-76.62M
-157.86%-21.85M
Minority interest income
Net income attributable to the parent company
171.68%31.38M
111.88%20.89M
177.45%43.36M
133.95%26.01M
78.46%-4.71M
-104.57%-43.77M
-351.04%-175.85M
-395.59%-55.98M
-605.42%-76.62M
-157.86%-21.85M
Preferred stock dividends
Other preferred stock dividends
1K
415K
0
0
Net income attributable to common stockholders
171.68%31.38M
111.64%20.48M
176.71%42.94M
133.95%26.01M
78.46%-4.71M
-104.57%-43.77M
-351.04%-175.85M
-395.59%-55.98M
-605.42%-76.62M
-157.86%-21.85M
Basic earnings per share
163.16%0.6
109.13%0.4
164.57%0.82
126.78%0.49
84.21%-0.09
-61.02%-0.95
-85.59%-4.38
-256.16%-1.27
-92.63%-1.83
29.63%-0.57
Diluted earnings per share
162.11%0.59
108.90%0.39
162.99%0.8
125.68%0.47
84.21%-0.09
-61.02%-0.95
-85.59%-4.38
-256.16%-1.27
-92.63%-1.83
29.63%-0.57
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 94.6M190.41M91.73M66.02M32.66M00000
Operating revenue --94.6M--190.41M--91.73M--66.02M--32.66M--0--0--0--0--0
Cost of revenue 1.2M2.7M863K1.14M696K00000
Gross profit 93.41M187.71M90.87M64.88M31.96M00000
Operating expense 44.11%61.64M-6.33%172.76M-14.21%50.44M-46.86%42.16M60.93%37.39M85.39%42.78M376.93%184.43M358.25%58.79M747.51%79.34M179.55%23.23M
Selling and administrative expenses 72.15%50.37M24.81%132.13M9.58%40.88M-31.39%33.75M159.33%28.24M245.36%29.26M685.26%105.86M801.04%37.3M1,382.73%49.2M243.61%10.89M
-General and administrative expense 72.15%50.37M----------------245.36%29.26M685.26%105.86M801.04%37.3M1,382.73%49.2M243.61%10.89M
Research and development costs -16.59%11.27M-48.29%40.63M-55.52%9.56M-72.11%8.41M-25.89%9.15M-7.43%13.52M211.91%78.57M147.28%21.49M398.73%30.14M140.07%12.34M
Operating profit 174.25%31.76M108.11%14.95M168.77%40.43M128.64%22.72M76.65%-5.42M-85.39%-42.78M-376.93%-184.43M-358.25%-58.79M-747.51%-79.34M-179.55%-23.23M
Net non-operating interest income expense 84.52%3.64M-2.92%11.48M20.64%3.78M8.68%3.91M-39.71%1.82M-5.15%1.97M358.53%11.82M46.18%3.13M1,966.67%3.6M1,950.34%3.01M
Non-operating interest income 47.91%4.93M40.66%16.95M52.45%5.13M47.33%5.3M5.94%3.19M60.38%3.33M367.49%12.05M56.95%3.37M1,966.67%3.6M1,950.34%3.01M
Non-operating interest expense -5.07%1.29M2,270.56%5.48M483.98%1.35M--1.39M--1.38M--1.36M--231K--231K--0--0
Other net income (expense) 83.69%-484K-70.76%-5.54M-161.16%-854K29.99%-614K32.74%-1.1M-639.90%-2.97M-11.95%-3.24M46.48%-327K47.61%-877K-424.68%-1.64M
Special income (charges) 83.69%-484K-70.76%-5.54M-161.16%-854K29.99%-614K32.74%-1.1M-639.90%-2.97M-19.45%-3.24M69.75%-327K14.10%-877K-423.00%-1.64M
-Less:Restructuring and merger&acquisition -83.69%484K70.76%5.54M161.16%854K-29.99%614K-32.74%1.1M639.90%2.97M19.45%3.24M-69.75%327K-14.10%877K423.00%1.64M
Income before tax 179.76%34.91M111.88%20.89M177.45%43.36M133.95%26.01M78.46%-4.71M-104.57%-43.77M-351.04%-175.85M-395.59%-55.98M-605.42%-76.62M-157.86%-21.85M
Income tax 3.54M
Net income 171.68%31.38M111.88%20.89M177.45%43.36M133.95%26.01M78.46%-4.71M-104.57%-43.77M-351.04%-175.85M-395.59%-55.98M-605.42%-76.62M-157.86%-21.85M
Net income continuous Operations 171.68%31.38M111.88%20.89M177.45%43.36M133.95%26.01M78.46%-4.71M-104.57%-43.77M-351.04%-175.85M-395.59%-55.98M-605.42%-76.62M-157.86%-21.85M
Minority interest income
Net income attributable to the parent company 171.68%31.38M111.88%20.89M177.45%43.36M133.95%26.01M78.46%-4.71M-104.57%-43.77M-351.04%-175.85M-395.59%-55.98M-605.42%-76.62M-157.86%-21.85M
Preferred stock dividends
Other preferred stock dividends 1K415K00
Net income attributable to common stockholders 171.68%31.38M111.64%20.48M176.71%42.94M133.95%26.01M78.46%-4.71M-104.57%-43.77M-351.04%-175.85M-395.59%-55.98M-605.42%-76.62M-157.86%-21.85M
Basic earnings per share 163.16%0.6109.13%0.4164.57%0.82126.78%0.4984.21%-0.09-61.02%-0.95-85.59%-4.38-256.16%-1.27-92.63%-1.8329.63%-0.57
Diluted earnings per share 162.11%0.59108.90%0.39162.99%0.8125.68%0.4784.21%-0.09-61.02%-0.95-85.59%-4.38-256.16%-1.27-92.63%-1.8329.63%-0.57
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More